Benefits of Trimetazidine in MAFLD Pateints - Trial NCT06140953
Access comprehensive clinical trial information for NCT06140953 through Pure Global AI's free database. This Phase 2 trial is sponsored by October 6 University and is currently Recruiting. The study focuses on Non-Alcoholic Fatty Liver Disease. Target enrollment is 60 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
October 6 University
Timeline & Enrollment
Phase 2
Dec 10, 2023
Sep 01, 2025
Primary Outcome
incidence in mafld,incidence in mafld,incidence in mafld
Summary
Objective of this study is to determine the clinical benefits of trimetazidine in improvement
 of MAFLD
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06140953
Non-Device Trial